@article{article, title = {{Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.}}, publisher = {{Adis}}, url = {{http://eprints.whiterose.ac.uk/119850/ }}, year = {{2018}}, month = {{1}}, author = {{Squires H and Pandor A and Thokala P and Stevens JW and Kaltenthaler E and Clowes M and Coleman R and Wyld L}}, doi = {{10.1007/s40273-017-0556-7}}, volume = {{36}}, journal = {{PharmacoEconomics}}, issue = {{1}}, pages = {{29-38}}, note = {{Accessed on 2025/04/16}}}